BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15863213)

  • 1. Immune evasion strategies of pediatric precursor-B acute lymphoblastic leukemia after allogeneic bone marrow transplantation-a case study.
    Barbaric D; Wynne K; Aslanian S; Bond M; Reid GS
    Leuk Res; 2005 Jun; 29(6):711-4. PubMed ID: 15863213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia.
    Huck K; Laws HJ; Meisel R; Traeger A; Bernbeck B; Schonberger S; Stackelberg VA; Pape H; Dilloo D
    Haematologica; 2006 May; 91(5 Suppl):ECR07. PubMed ID: 16709515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of HGF on graft-versus-host disease and graft-versus-leukemia after allogeneic bone marrow transplantation in acute lymphoblastic leukemia mice].
    Xia YJ; Gao QP; Wan CC; Cheng FJ; Liu ZX; Guo RC
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):404-7. PubMed ID: 16251021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
    J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of acute leukemia in donor cells after bone marrow transplantation: documentation by in situ DNA hybridization.
    Mouratidou M; Sotiropoulos D; Deremitzaki K; Spathas DH; Hoffbrand AV; Prentice HG; Papanastasiou K; Tsakanikas S; Tsaftaridis P; Stamatelou M
    Bone Marrow Transplant; 1993 Jul; 12(1):77-80. PubMed ID: 8374538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential gene expression in acute lymphoblastic leukemia cells surviving allogeneic transplant.
    Shand JC; Jansson J; Hsu YC; Campbell A; Mullen CA
    Cancer Immunol Immunother; 2010 Nov; 59(11):1633-44. PubMed ID: 20602231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
    Arellano ML; Langston A; Winton E; Flowers CR; Waller EK
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study.
    Choi SJ; Lee JH; Lee JH; Kim S; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Jang S; Park CJ; Chi HS; Lee KH
    Bone Marrow Transplant; 2005 Jul; 36(2):163-9. PubMed ID: 15937507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts.
    Troeger A; Glouchkova L; Escherich G; Siepermann M; Hanenberg H; Janka-Schaub G; Göbel U; Ackermann B; Dilloo D
    Klin Padiatr; 2008; 220(6):353-7. PubMed ID: 18949670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
    Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
    Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosai-Dorfman disease following bone marrow transplantation for pre-B cell acute lymphoblastic leukemia.
    Ambati S; Chamyan G; Restrepo R; Escalon E; Fort J; Pefkarou A; Khatib ZA; Dehner LP
    Pediatr Blood Cancer; 2008 Sep; 51(3):433-5. PubMed ID: 18493991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation.
    Godder KT; Henslee-Downey PJ; Mehta J; Park BS; Chiang KY; Abhyankar S; Lamb LS
    Bone Marrow Transplant; 2007 Jun; 39(12):751-7. PubMed ID: 17450185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow Th2 cytokine expression as predictor for relapse in childhood acute lymphoblastic leukemia (ALL).
    Stachel D; Albert M; Meilbeck R; Kreutzer B; Haas RJ; Schmid I
    Eur J Med Res; 2006 Mar; 11(3):102-13. PubMed ID: 16751110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic related bone marrow transplantation in children--a single center experience.
    Chen SH; Hung IJ; Yang CP; Jaing TH; Fang EC; Yang SH; Tseng CK
    Acta Paediatr Taiwan; 2005; 46(6):352-5. PubMed ID: 16640037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
    Sánchez-García J; Serrano J; Gómez P; Martínez F; Martín C; Román-Gómez J; Rodríguez A; Herrera C; García JM; Alvarez MA; Torres A
    Haematologica; 2006 Mar; 91(3):340-7. PubMed ID: 16531257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation].
    Kuroki F; Goto H; Yanagimachi M; Kajiwara R; Fujii H; Isaki S; Takahashi H; Ikuta K; Yokota S
    Rinsho Ketsueki; 2006 Jul; 47(7):639-44. PubMed ID: 16910574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of cyclosporin A on acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents with acute lymphoblastic leukemia.
    Teuffel O; Schrauder A; Sykora KW; Zimmermann M; Reiter A; Welte K; Schrappe M
    Bone Marrow Transplant; 2005 Jul; 36(2):145-50. PubMed ID: 15908976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal sepsis due to mycobacterium tuberculosis after allogeneic bone marrow transplantation.
    Kindler T; Schindel C; Brass U; Fischer T
    Bone Marrow Transplant; 2001 Jan; 27(2):217-8. PubMed ID: 11281394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.